New Data from Gene Therapy Clinical Trials in DMD

Updates in Safety and Efficacy of Gene Therapy for DMD

The Latest Updates in Duchenne Muscular Dystrophy

Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (June 2021)

Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (October 2021)

Gene Therapy for DMD How it Works and the Ongoing Clinical Trials

Webinar: ENVISION Study Update with Sarepta Therapeutics

First Approved Gene Therapy for Muscular Dystrophy Brings Hope to Kids Everywhere

DMD Gene Therapy Clinical Trials

In the Pipeline: Gene Therapy - Sarepta Therapeutics

Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion

CureDuchenne and REGENXBIO Webinar: RGX-202 - REGENXBIO’s investigational gene therapy for DMD

New Exon Skipping Drug in Clinical Development for Duchenne Muscular Dystrophy

Three Gene Therapy Study Updates for Duchenne Muscular Dystrophy

Introducing a New Limb girdle Muscular Dystrophy Natural History Study

Management of Duchenne Muscular Dystrophy - An Update

Investigational Gene Therapy (SRP-9001) Shows Promise in Duchenne Muscular Dystrophy Patients

In the Pipeline: Restoring Dystrophin - Sarepta Therapeutics (RNA Targeted Therapies)

FDA Approved Gene Therapy | Duchenne Muscular Dystrophy

Mechanism of Action of SRP-9001, A Gene Therapy For Duchenne Muscular Dystrophy